From: Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites
Characteristic | Value |
---|---|
Age (year) | |
 Mean (±SD) | 52.21 (±11.00) |
 Range | 27.0–84.0 |
Gender | |
 Male | 25 (7.3%) |
 Female | 318 (92.7%) |
Site of primary cancer | |
 Tongue | 132 (38.5%) |
 Mouth floor | 12 (3.5%) |
 Lip | 24 (7.0%) |
 Buccal mucosa | 126 (36.7%) |
 Alveolar ridge | 31 (9.0%) |
 Hard palate | 2 (0.6%) |
 Retromolar trigone | 16 (4.7%) |
Pathologic tumor status | |
 1 | 91 (26.5%) |
 2 | 119 (34.7%) |
 3 | 24 (7.0%) |
 4a | 85 (24.8%) |
 4b | 24 (7.0%) |
Pathologic N stage | |
 N0 | 201 (58.6%) |
 N1 | 47 (13.7%) |
 N2b | 79 (23.0%) |
 N2c | 15 (4.4%) |
 N3 | 1 (0.3%) |
Pathologic stage | |
 I | 76 (22.2%) |
 II | 66 (19.2%) |
 III | 43 (12.5%) |
 IVa | 133 (38.8%) |
 IVb | 25 (7.3%) |